Isoniazid is an anti-tuberculosis drug, used commonly for treatment and prophylaxis of tuberculosis. Acute isoniazid intoxication is characterized by a clinical triad consisting of metabolic acidosis resistant to treatment with sodium bicarbonate, seizures which may be fatal and refractory to standard anticonvulsant therapy, and coma. Treatment requires admission to the intensive care unit for ventilatory support, management of seizures and metabolic acidosis. Pyridoxine, in a dose equivalent to the amount of isoniazid ingested, is the only effective antidote. We report the successful treatment of two isoniazid intoxication cases: the case of a child developing an accidental acute isoniazid intoxication and an adult case of isoniazid intoxication with the intent of suicide.
Tuberculosis is still one of the most destructive infectious diseases in the world and causes millions of deaths even in the early twenty-first century 1 . Isoniazid is the most important drug in the treatment of all types of tuberculosis; it is well-tolerated, inexpensive and effective. Although isoniazid must be used with other drugs in the treatment of tuberculosis, it can also be used alone in the prophylaxis of tuberculosis.
Isoniazid produces acute toxic effects by competing with brain pyridoxal 5-phosphate for the enzyme glutamic acid decarboxylase. This results in lower levels of gamma-aminobutyric acid (GABA), which leads to uninhibited electrical activity manifested as seizures 2 . Isoniazid also inhibits the hepatic conversion of lactate to pyruvate, resulting in lactic acidosis 3 . Seizures that are refractory to conventional anticonvulsant therapy 2, 4 , metabolic acidosis refractory to treatment with sodium bicarbonate 3 , and coma 5 are all suggestive of isoniazid intoxication.
Prognosis depends on rapid diagnosis and the treatment of possible complications. This report presents the successful treatment of two cases of isoniazid intoxication.
CASE HISTORIES
Two patients admitted to our ICU in the first three months of 2003 are presented in this report. One ingested isoniazid orally with the intent of committing suicide, and the other accidentally. The demographic data, initial symptoms and laboratory findings are shown in Table 1 . The measurement of serum isoniazid levels and qualitative identification in the urine could not be obtained. Diagnosis depended on the history of empty bottles found by the families and clinical findings.
Case 1
A seven-year-old girl, weighing 25 kg, whose father was using isoniazid for tuberculosis prophylaxis, was admitted unconscious to the emergency department of the hospital with convulsions. She had accidentally ingested 1.5 g of isoniazid at home. She was intubated in order to secure her airway and to start positive pressure ventilation. Cardiovascular and gastrointestinal examination were normal. Arterial blood pressure (BP) and heart rate (HR) were 90/60 mmHg and 140 bpm respectively. A 5 mg bolus of diazepam was administered intravenously to control generalized tonic-clonic seizures. A thiopentone infusion was commenced because of lack of response to diazepam. Simultaneously pyridoxine 1.5 g was commenced intravenously. Sodium bicarbonate 30 mmol was administered intravenously to correct the metabolic acidosis.
After intubating the patient, gastric lavage was performed and activated charcoal was administered. The results of initial laboratory tests were: blood glucose 159 mg/dl; blood urea 26 mg/dl; sodium 140 mEq/l; potassium 4.2 mEq/l; white cell count (WCC) 28700x10 9 /l; haemoglobin (Hb) 12.1 g/dl; haematocrit (Hct), 35.1%; pH 7.01; P a O 2 67.5 mmHg; P a CO 2 45.9 mmHg; base excess -9.9 mmol/l. Ketonuria was not detected.
When the patient was fully conscious 36 hours after admission, she was weaned from the ventilator and extubated. She was discharged at the end of the sixth day. Her liver enzyme levels were followed daily in the ICU and after one week of her discharge and remained normal.
Case 2
An 18-year-old woman was admitted unconscious to the ICU with a history of generalized tonic-clonic seizure at home. She had consumed about 2 g of isoniazid, with the intent of committing suicide. Her protective airway reflexes were normal. She was monitored with the support of oxygen by facemask. Physical examination showed a BP of 150/70 mmHg, HR 134 bpm. The results of initial laboratory tests were: blood glucose 246 mg/dl; blood urea 46 mg/dl; sodium 142 mEq/l; potassium 4.0 mEq/l, Hb 15.3 g/dl; Htc 43.7%; WCC 14700x10 9 /l, pH 7.00; P a O 2 90.6 mmHg; P a CO 2 47.3 mmHg; base excess -19.7 mmol/l. Ketonuria was not detected.
Sodium bicarbonate 40 mmol, diazepam 20 mg and pyridoxine 2 g were administered intravenously. An additional dose of pyridoxine 1.0 g was used to treat coma after the seizures were controlled. The blood gas and acid-base analysis became normal eight hours after admission. Additional treatment modalities included gastric lavage and administration of activated charcoal. She remained lethargic for three days. The patient was discharged from the hospital seven days after the admission. Her liver enzyme levels became elevated on the fourth day and returned to normal by day 15.
DISCUSSION
Isoniazid is a hydrazid derivative of isonicotinic acid and is absorbed rapidly from the gastrointestinal tract, reaching peak levels in one to two hours. The distribution volume is 0.6 to 0.7 l/kg. It is excreted in 24 hours in patients with normal renal function. Metabolism takes place by enzymatic acetylation and hydrolysis in liver. Plasma half-life is 0.5 to 1.6 hours by fast acetylation, two to five hours by slow acetylation 6, 7 .
Isoniazid toxicity may occur with doses as low as 10-30 mg/kg. Typical symptoms of acute isoniazid intoxication are nausea, vomiting, blurred vision, slurred speech, dizziness and urinary retention. At doses over 20 mg/kg, hallucinations, recurrent seizures and coma may be seen. Furthermore, tachycardia, hypotension, hyperthermia, severe metabolic acidosis, hyperglycemia, hyperkalemia and increased urinary excretion of pyridoxine may also be observed at higher doses. Death may occur at doses over 50 mg/kg 6 .
The initial symptom in both of our patients was a seizure. Estimated time for drug ingestion was almost two hours prior to transfer to our hospital from other health institutions. Both patients were young and female. Both had high anion gap metabolic acidosis, resistant to treatment with bicarbonate. The patients had hyperglycemia and leukocytosis. Increased hepatic enzyme levels were seen in the second patient on the fourth day but not in the first patient. The first patient was intubated and positive pressure ventilation was started as the patient had no protective airway reflexes. Extubation took place 36 hours after ventilation support started. Both were treated with general supportive measures including airway protection, gastric lavage, activated charcoal administration, sodium bicarbonate infusion, fluid replacement and intravenous diazepam and thiopentone for seizures. In both cases pyridoxine infusion was administered intravenously in doses equal to the amount of isoniazid ingested. The patients regained consciousness after the pyridoxine infusion. The patients were discharged after seven days.
The metabolite of isoniazid, isoniazid hydrazone is produced by dehydrazination which inhibits formation of pyridoxal 5' phosphate (active form of Vitamin B6) from pyridoxine by inhibiting pyridoxine phosphokinase competitively 6 . Other metabolites, hydrazines and hydrazides formed by acetylation and hydrolysis inhibit pyridoxal 5' phosphate 6, 7 . Pyridoxal 5' phosphate is a cofactor in GABA synthesis from glutamic acid by decarboxylation. Hence, there is a decrease in GABA production. Neurons are more excitable and the seizure threshold lowered when I. TOPCU, E. A. YENTUR ET AL GABA is blocked 8 . Isoniazid also causes a lactic acidosis by inhibiting the conversion of lactate to pyruvate. Other researchers reported that the major component of this acidosis is the accumulation of lactate secondary to seizure activity 3 . Treatment with intravenous sodium bicarbonate does not terminate the acidosis when seizures continue. However, bicarbonate should be given if the serum pH is lower than 7.2 or the acidosis does not rapidly resolve after seizure control 9, 10 . Hepatic dysfunction may occur due to increased production of acetylhydrazine, a metabolite of isoniazid 11 . Hyperglycaemia may result from blockage of specific steps in the Krebs cycle that require nicotinamide-adenine dinucleotide and from stimulation of glucagon secretion 12 .
Seizures caused by isoniazid are refractory to anticonvulsant therapy 2 . For this reason, isoniazid overdose should be considered in patients with seizures refractory to therapy. Drugs that enhance GABA levels such as diazepam should be effective in isoniazid-induced seizures: however, Chin et al 13 reported that diazepam alone is not effective, but when combined with pyridoxine achieved complete protection from seizures and death. Hence, it is recommended that acute isoniazid poisoning treatment include both pyridoxine and diazepam 13 . Pyridoxine must be used as a specific antidote in neurological toxicity according to the metabolic effect of isoniazid. Pyridoxine is effective in reversing coma. It should be used in doses equal to the amount of isoniazid ingested in the treatment of seizure activity 12, 14 . If the amount of isoniazid ingested is unknown, a dose of parenteral pyridoxine of 5 g may be administered to an adult or 70 mg/kg to a maximum of 5 g in a child 14 . This dose is given intravenously over 30 to 60 minutes for patients without seizures and over three to five minutes in those with seizures 14 . The doses can be repeated at 5 to 20 minutes intervals until seizures cease or consciousness is regained. Pyridoxine is effective in treating not only isoniazid-induced seizures, but also the changes in mental status associated with this overdose. The dose required to produce consciousness may be higher than that required to control seizures 2 .
After initial stabilization of life-threatening symptoms, gastrointestinal decontamination using activated charcoal should be performed. Because of the potential for rapid development of coma and seizures, induced emesis is not recommended 10 . As the half-life of isoniazid is relatively short (one to five hours, depending on acetylator status) treatment with good supportive care, pyridoxine and GABAenhancing anticonvulsants is generally sufficient and enhanced elimination may not be needed.
As the incidence of tuberculosis is increasing in some countries, isoniazid intoxication should be suspected in any patient presenting with metabolic acidosis and seizures, particularly if resistant to conventional anticonvulsants. Prognosis in acute isoniazid intoxication largely depends on rapid diagnosis and treatment of complications.
